The Veterinary Medicines Working Group facilitates engagement between the APVMA and registrants, permit holders, industry representatives, and other regulated entities on practical and operational matters related to the regulation of veterinary medicines.

On this page:

Purpose

The Veterinary Medicines Working Group provides a forum for registrants (fee payers) to discuss fees and levies, application processes, regulatory requirements, and operational challenges. It aims to enhance transparency, improve regulatory efficiency, and ensure that industry perspectives are considered.

By fostering open dialogue, the group will support continuous improvement in regulatory administration and promote a collaborative approach to addressing issues that impact regulated entities and the APVMA.

The draft terms of reference are available for member comment.

Eligibility criteria

Membership in the Veterinary Medicines Working Group is open to registrants, permit holders and other regulated entities and their representatives who have a direct interest in the regulatory processes, fees, and operational matters related to veterinary medicines.

Expressions of interest (maximum of 2 pages) may be submitted at any time.

To be eligible, applicants must:

  • Be a regulated entity or an authorised representative.
  • Demonstrate direct involvement or expertise in one or more of the following:
    • Application processes and regulatory requirements for veterinary medicines
    • Fees, levies, and cost recovery arrangements
    • Compliance and regulatory operations
    • Industry-specific regulatory challenges
  • Have the capacity to engage constructively, including reviewing materials, attending meetings, and providing informed feedback on operational matters.
  • Commit to representing industry perspectives in a collaborative and solutions-focused manner.
  • Be available to attend quarterly meetings and participate in discussions as needed.
  • Disclose any potential conflicts of interest and abide by confidentiality requirements where necessary.

Membership will be determined through an Expression of Interest (EOI) process, with selection based on sector representation, expertise, and the need for a balanced range of perspectives.

Assessment criteria 

The EOI (maximum of 2 pages) will be assessed based on the following criteria to ensure a balanced and effective working group:

  • Relevance to the industry
    • The applicant is a regulated entity or an authorised representative.
    • Demonstrates direct involvement in regulatory processes, fees, levies, or operational matters.
  • Expertise and experience
    • Demonstrates an understanding of regulatory processes, application requirements, fees and levies, or industry-specific operational challenges.
    • Has experience engaging with regulatory bodies on compliance or administrative processes.
    • Brings insights that will contribute to constructive discussions and practical outcomes.
  • Ability to engage and contribute
    • Willingness and ability to actively participate in meetings, review documents, and provide informed feedback.
    • Demonstrated ability to engage constructively in industry discussions and represent the perspectives of registrants.
  • Sector representation
    • Ensures a balanced representation across different industry sectors, including large and small registrants.
    • Considers geographic and sectoral diversity to reflect a broad range of industry interests.

Additional considerations

Applicants with conflicts of interest must outline how they will manage these appropriately.

The APVMA may prioritise applicants to ensure diversity of representation and avoid over-representation from a single company or sector.

Meeting summaries

Meetings have not yet been scheduled for 2025.
 

Content last updated:
Content last reviewed: